0 5

Cited 0 times in

Cited 0 times in

Additive renoprotective effects of oral calcitriol on patients with IgA nephropathy receiving RAS blockers

DC Field Value Language
dc.contributor.authorJoo, Young Su-
dc.contributor.authorChang, Tae-Ik-
dc.contributor.authorKim, Dong Ki-
dc.contributor.authorHan, Seung Hyeok-
dc.contributor.authorKang, Shin-Wook-
dc.contributor.authorYoo, Tae-Hyun-
dc.date.accessioned2025-12-23T02:40:55Z-
dc.date.available2025-12-23T02:40:55Z-
dc.date.created2025-12-11-
dc.date.issued2025-11-
dc.identifier.issn0931-0509-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/209530-
dc.description.abstractBackground Patients with immunoglobulin A nephropathy (IgAN) and moderate proteinuria are at risk of progressive renal failure despite the maximal use of renin-angiotensin system blockers (RASBs). This study evaluated the efficacy of active vitamin D in reducing proteinuria in patients with IgAN receiving RASBs.Methods In this double-blind, placebo-controlled trial, we enrolled biopsy-confirmed patients with IgAN and persistent proteinuria (0.5-3.5 g/day) after maximal use of RASBs. Patients were randomized to receive either 0.25 mu g/day of calcitriol or placebo for 12 months. The primary outcomes were the change in the mean urinary protein:creatinine ratio (UPCR) and daily urinary protein excretion during the treatment.Results A total of 138 patients from six medical centres were enrolled and assigned to receive a placebo (n = 69) or 0.25 mu g of calcitriol (n = 69) and 115 patients (83.3%) completed the study. The calcitriol group showed a greater reduction in geometric means of UPCR {mean difference -187 mg/g [95% confidence interval (CI) -370.6 to -4.0], P = .04} and urinary albumin:creatinine ratio [-162 mg/g (95% CI -290.9 to -34.6), P = .01] than placebo. Changes in daily urinary protein excretion were -3.5% (from 1.32 to 1.02 g/day) in the control group and -13.1% (from 1.29 to 0.97 g/day) in the calcitriol group, without any statistically significant differences (P = .11). The annual decrease of the estimated glomerular filtration rate (eGFR) was -0.32 ml/min/1.73 m2 (95% CI -2.54 to 1.99) in the calcitriol group and -3.64 ml/min/1.73 m2 (95% CI -5.70 to -1.58) in the placebo group (calcitriol versus placebo over time, P = .02). Adverse events were comparable between the groups.Conclusion The addition of 0.25 mu g/day calcitriol to RASBs safely lowered residual proteinuria and slowed the eGFR decline in patients with IgAN, suggesting a potential therapeutic role for calcitriol in this population.-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfNEPHROLOGY DIALYSIS TRANSPLANTATION-
dc.relation.isPartOfNEPHROLOGY DIALYSIS TRANSPLANTATION-
dc.titleAdditive renoprotective effects of oral calcitriol on patients with IgA nephropathy receiving RAS blockers-
dc.typeArticle-
dc.contributor.googleauthorJoo, Young Su-
dc.contributor.googleauthorChang, Tae-Ik-
dc.contributor.googleauthorKim, Dong Ki-
dc.contributor.googleauthorHan, Seung Hyeok-
dc.contributor.googleauthorKang, Shin-Wook-
dc.contributor.googleauthorYoo, Tae-Hyun-
dc.identifier.doi10.1093/ndt/gfaf187-
dc.relation.journalcodeJ02316-
dc.identifier.eissn1460-2385-
dc.identifier.pmid41178795-
dc.identifier.urlhttps://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfaf187/8251687-
dc.subject.keywordcalcitriol-
dc.subject.keywordIgA nephropathy-
dc.subject.keywordimmunoglobulin A nephropathy-
dc.subject.keywordvitamin D-
dc.contributor.affiliatedAuthorJoo, Young Su-
dc.contributor.affiliatedAuthorHan, Seung Hyeok-
dc.contributor.affiliatedAuthorKang, Shin-Wook-
dc.contributor.affiliatedAuthorYoo, Tae-Hyun-
dc.identifier.wosid001605979700001-
dc.identifier.bibliographicCitationNEPHROLOGY DIALYSIS TRANSPLANTATION, 2025-11-
dc.identifier.rimsid90311-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorcalcitriol-
dc.subject.keywordAuthorIgA nephropathy-
dc.subject.keywordAuthorimmunoglobulin A nephropathy-
dc.subject.keywordAuthorvitamin D-
dc.subject.keywordPlusIMMUNOGLOBULIN-A NEPHROPATHY-
dc.subject.keywordPlusNATURAL-HISTORY-
dc.subject.keywordPlusRENAL SURVIVAL-
dc.subject.keywordPlusKIDNEY-DISEASE-
dc.subject.keywordPlusDOUBLE-BLIND-
dc.subject.keywordPlusPARICALCITOL-
dc.subject.keywordPlusALBUMINURIA-
dc.subject.keywordPlusPROTEINURIA-
dc.subject.keywordPlusPREDICTION-
dc.subject.keywordPlusREDUCTION-
dc.type.docTypeArticle; Early Access-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryTransplantation-
dc.relation.journalWebOfScienceCategoryUrology & Nephrology-
dc.relation.journalResearchAreaTransplantation-
dc.relation.journalResearchAreaUrology & Nephrology-
dc.identifier.articlenogfaf187-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.